Ciaftalan

Ciaftalan

SCHEMBL4415382

I.c1ccc2c(c1)-c1nc-2nc2[nH]c(nc3nc(nc4[nH]c(n1)c1ccccc41)-c1ccccc1-3)c1ccccc21

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Ciaftalan. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
TDP1 Q9NUW8 4/20 0.45
RECQL P46063 2/20 0.45
THRB P10828 1/20 0.45
APEX1 P27695 1/20 0.45
BLM P54132 1/20 0.45
CA5A P35218 1/20 0.40
HSD17B10 Q99714 4/20 0.35
CYP1A2 P05177 3/20 0.35
CYP3A4 P08684 3/20 0.35
CYP2D6 P10635 3/20 0.35
CYP2C19 P33261 3/20 0.35
USP2 O75604 1/20 0.35
ALOX15 P16050 1/20 0.35
CLK4 Q9HAZ1 1/20 0.35
ALDH1A1 P00352 4/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
MAPK1 P28482 3/20 0.34
CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ciaftalan SCHEMBL6037601 1.00 MEN1 (0.45) MEN1KMT2ATDP1RECQLTHRB
Ciaftalan SCHEMBL4970464 1.00 MEN1 (0.45) MEN1KMT2ATDP1RECQLTHRB
Ciaftalan SCHEMBL14690839 1.00 MEN1 (0.45) MEN1KMT2ATDP1RECQLTHRB
Ciaftalan SCHEMBL8909497 0.98 MEN1 (0.44) MEN1KMT2ATDP1RECQLTHRB
Ciaftalan SCHEMBL6037014 0.98 MEN1 (0.44) MEN1KMT2ATDP1RECQLTHRB
Ciaftalan SCHEMBL8909846 0.98 MEN1 (0.44) MEN1KMT2ATDP1RECQLTHRB
Ciaftalan SCHEMBL29356273 0.98 MEN1 (0.46) MEN1KMT2ATDP1RECQLTHRB
SCHEMBL813083 0.98 MEN1 (0.46) MEN1KMT2ATDP1RECQLTHRB
Ciaftalan SCHEMBL29360952 0.98 MEN1 (0.46) MEN1KMT2ATDP1RECQLTHRB
Ciaftalan SCHEMBL1728179 0.98 MEN1 (0.46) MEN1KMT2ATDP1RECQLTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110520894-A Method of tracking a source display panel of an electronic device that captures an illegal copy of an image by a camera and electronic device for tracking an illegal copy of an image captured by a camera from a source display panel of an electronic device BOE TECHNOLOGY GROUP CO LTD 2019-11-29 CN disclosed
US-8242262-B2 Process for preparing chlorides of phthalocyanine derivatives comprising at least a quaternary ammonium group L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA'DI ESERCIZIO S.P.A. (IT) 2012-08-14 US disclosed
CN-101193893-B Process for preparing chlorides of phthalocyanine derivatives comprising at least a quaternary ammonium group L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA'DI ESERCIZIO S.P.A. (IT) 2011-12-14 CN disclosed
EP-1883640-B1 PROCESS FOR PREPARING CHLORIDES OF PHTHALOCYANINE DERIVATIVES COMPRISING AT LEAST A QUATERNARY AMMONIUM GROUP MOLTENI & C (IT) 2009-08-26 EP disclosed
US-20090131393-A1 Process for Preparing Chlorides of Phthalocyanine Derivatives Comprising at Least a Quaternary Ammonium Group L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA' DI ESERCIZIO S.P.A. (IT) 2009-05-21 US disclosed
CN-101193893-A Process for preparing chlorides of phthalocyanine derivatives comprising at least a quaternary ammonium group MOLTENI & C (IT) 2008-06-04 CN disclosed
EP-1883640-A2 PROCESS FOR PREPARING CHLORIDES OF PHTHALOCYANINE DERIVATIVES COMPRISING AT LEAST A QUATERNARY AMMONIUM GROUP L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA' DI ESERCIZIO SOCIETA' PER AZIONI (IT) 2008-02-06 EP disclosed
WO-2006117396-A2 PROCESS FOR PREPARING CHLORIDES OF PHTHALOCYANINE DERIVATIVES COMPRISING AT LEAST A QUATERNARY AMMONIUM GROUP L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA' DI ESERCIZIO S.P.A. (IT) 2006-11-09 WO disclosed
US-5656751-A COMPLEX OF PHTHALOCYANINE, A PHTHALOCYANINE DERIVATIVE, A PHTHALOCYANINE WITH CENTRAL METAL OR NONMETAL AND IODINE; EXCELLENT HEAT AND WEATHER RESISTANCE KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) 1997-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131393-A1 Process for Preparing Chlorides of Phthalocyanine Derivatives Comprising at Least a Quaternary Ammonium Group PHLPP1, PHPT1, PHLPP2 MEN1 754/4885KMT2A 673/4885TDP1 3855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.